Contineum Therapeutics, Inc. (CTNM)
Nasdaq: CTNM · CIK 0001855175 · United States
Every official Contineum Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CTNM filings
Contineum Therapeutics, Inc. documents
- Contineum Therapeutics, Inc. 10-K 2026CTNM 10-K 2026: annual report for fiscal 2026
- Contineum Therapeutics, Inc. 10-K 2025CTNM 10-K 2025: annual report for fiscal 2025
- Contineum Therapeutics, Inc. 10-K 2024CTNM 10-K 2024: annual report for fiscal 2024
- Contineum Therapeutics, Inc. 10-K 2023CTNM 10-K 2023: annual report for fiscal 2023
- Contineum Therapeutics, Inc. 10-K 2022CTNM 10-K 2022: annual report for fiscal 2022
- Contineum Therapeutics, Inc. 10-Q 2026CTNM 10-Q 2026: quarterly report for fiscal 2026
- Contineum Therapeutics, Inc. 10-Q 2025CTNM 10-Q 2025: quarterly report for fiscal 2025
- Contineum Therapeutics, Inc. 10-Q 2024CTNM 10-Q 2024: quarterly report for fiscal 2024
- Contineum Therapeutics, Inc. 10-Q 2023CTNM 10-Q 2023: quarterly report for fiscal 2023
- Contineum Therapeutics, Inc. 10-Q 2022CTNM 10-Q 2022: quarterly report for fiscal 2022
- Contineum Therapeutics, Inc. 8-K 2026CTNM 8-K 2026: current report for fiscal 2026
- Contineum Therapeutics, Inc. 8-K 2025CTNM 8-K 2025: current report for fiscal 2025
- Contineum Therapeutics, Inc. 8-K 2024CTNM 8-K 2024: current report for fiscal 2024
- Contineum Therapeutics, Inc. 8-K 2023CTNM 8-K 2023: current report for fiscal 2023
- Contineum Therapeutics, Inc. 8-K 2022CTNM 8-K 2022: current report for fiscal 2022
- Contineum Therapeutics, Inc. DEF 14A 2026CTNM DEF 14A 2026: proxy statement for fiscal 2026
- Contineum Therapeutics, Inc. DEF 14A 2025CTNM DEF 14A 2025: proxy statement for fiscal 2025
- Contineum Therapeutics, Inc. DEF 14A 2024CTNM DEF 14A 2024: proxy statement for fiscal 2024
- Contineum Therapeutics, Inc. DEF 14A 2023CTNM DEF 14A 2023: proxy statement for fiscal 2023
- Contineum Therapeutics, Inc. DEF 14A 2022CTNM DEF 14A 2022: proxy statement for fiscal 2022
- Contineum Therapeutics, Inc. Form 4 2026CTNM Form 4 2026: insider trading filing for fiscal 2026
- Contineum Therapeutics, Inc. Form 4 2025CTNM Form 4 2025: insider trading filing for fiscal 2025
- Contineum Therapeutics, Inc. Form 4 2024CTNM Form 4 2024: insider trading filing for fiscal 2024
- Contineum Therapeutics, Inc. Form 4 2023CTNM Form 4 2023: insider trading filing for fiscal 2023
- Contineum Therapeutics, Inc. Form 4 2022CTNM Form 4 2022: insider trading filing for fiscal 2022
- Contineum Therapeutics, Inc. S-1 2026CTNM S-1 2026: registration statement for fiscal 2026
- Contineum Therapeutics, Inc. S-1 2025CTNM S-1 2025: registration statement for fiscal 2025
- Contineum Therapeutics, Inc. S-1 2024CTNM S-1 2024: registration statement for fiscal 2024
- Contineum Therapeutics, Inc. S-1 2023CTNM S-1 2023: registration statement for fiscal 2023
- Contineum Therapeutics, Inc. S-1 2022CTNM S-1 2022: registration statement for fiscal 2022
- Contineum Therapeutics, Inc. 13F 2026CTNM 13F 2026: institutional holdings for fiscal 2026
- Contineum Therapeutics, Inc. 13F 2025CTNM 13F 2025: institutional holdings for fiscal 2025
- Contineum Therapeutics, Inc. 13F 2024CTNM 13F 2024: institutional holdings for fiscal 2024
- Contineum Therapeutics, Inc. 13F 2023CTNM 13F 2023: institutional holdings for fiscal 2023
- Contineum Therapeutics, Inc. 13F 2022CTNM 13F 2022: institutional holdings for fiscal 2022
More companies